Top compounds associated with response to ZFP14


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.29 6e-16
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 1e-12
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.26 1e-12
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-11
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 3e-11
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 1e-10
mRNA PX-12 CTRPv2 pan-cancer AAC 0.19 2e-10
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 3e-10
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 5e-10
mRNA nelarabine CTRPv2 pan-cancer AAC 0.24 1e-09
Download CSV